Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient

Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient

Enregistré dans:
Détails bibliographiques
Auteurs principaux: John Yeakel, MD, Aarthi Kannan, BA, Nicole Hook Rattigan, PhD, Maki Yamamoto, MD, Alexey Aleshin, MD, MBA, Jeremy P. Harris, MPhil, MD, Ling Gao, MD, PhD
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
circulating tumor DNA
hypofractionated radiation
Merkel cell carcinoma
T-VEC
Dermatology
RL1-803
Accès en ligne:https://doaj.org/article/83c88c6092e54f0f84f262e3833ad7ea
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/83c88c6092e54f0f84f262e3833ad7ea

Documents similaires